MedPath

Chlorzoxazone

Chlorzoxazone Tablets, USP 500 mg

Approved
Approval ID

7c6c02a1-1774-4332-babd-dff86f9638a0

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 12, 2024

Manufacturers
FDA

Bryant Ranch Prepack

DUNS: 171714327

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Chlorzoxazone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63629-9158
Application NumberANDA212254
Product Classification
M
Marketing Category
C73584
G
Generic Name
Chlorzoxazone
Product Specifications
Route of AdministrationORAL
Effective DateMarch 26, 2020
FDA Product Classification

INGREDIENTS (1)

CHLORZOXAZONEActive
Quantity: 500 mg in 1 1
Code: H0DE420U8G
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Chlorzoxazone - FDA Drug Approval Details